Announcements Trials
Browse Landscape

Phase

Phase 2 76Phase 3 31Phase 1 23Phase 1/2 12Phase NA 2Phase 2/3 2Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 6Stomach Neoplasms 3Upper Gastrointestinal Tumours 1Solid Tumor 1Small Cell Lung Carcinoma 1Rectal Neoplasms 1Neutropenia 1Colonic Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

Propofol 3Oxaliplatin 3Morphine 3Fentanyl 3Sevoflurane 2Ropivacaine 2Fluorouracil 2Capecitabine 2Bupivacaine 2Bevacizumab 2Acetaminophen 2polyethylene glycol 3350 1oxycodone-acetaminophen 1gatorade 1fish oil triglycerides 1Vitamin D 1Tranexamic Acid 1Tramadol 1Tegafur 1Sodium Chloride 1Simethicone 1Saline Solution 1Rivaroxaban 1Polyethylene Glycols 1Pirinitramide 1Panitumumab 1Orphenadrine 1Neuroleptanalgesia 1Midazolam 1Methadone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Colonic Neoplasms × Irinotecan × Clear all
NCT00559676 2011-05-16

Study of Biomarkers in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer

National Cancer Institute (NCI)

Phase 4 Completed
200 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡